Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
Giorgos Bamias, Georgios Kokkotis, Michalis Gizis, Christina Kapizioni, Konstantinos Κarmiris, Evgenia Koureta, Nikolaos Kyriakos, Georgios Leonidakis, Konstantinos Makris, Panagiotis Markopoulos, Georgios Michalopoulos, Spyridon Michopoulos, Ioannis Papaconstantinou, Dimitrios Polymeros, Spyros I. Siakavellas, Κonstantinos Τriantafyllou, Eftychia Tsironi, Emmanouela Tsoukali, Maria Tzouvala, Nikos Viazis, V. Xourafas, Eirini Zacharopoulou, Evanthia Zampeli, Konstantinos G. Zografos, George Papatheodoridis, Gerasimos Mantzaris
Topics & Concepts
VedolizumabUlcerative colitisMedicineTransplant surgeryHepatologyInternal medicineGastroenterologyCohortInflammatory bowel diseaseCohort studyColitisDiseaseInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesLiver Diseases and Immunity